Halozyme Therapeutics, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
HALO on Nasdaq
Location
12390 El Camino Real, San Diego, California

Insiders trading volume in the past year

Halozyme Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Helen Torley PRESIDENT AND CEO, Director $29 M -$3.88 M -11.8% Feb 23, 2024
Michael J. LaBarre Svp, Chief Technical Officer $9.16 M -$7.7 M -45.7% Jun 18, 2024
Connie Matsui Director $7.57 M Apr 25, 2024
Matthew L. Posard Director $5.17 M -$1.01 M -16.3% Jun 11, 2024
Jean Pierre Bizzari Director $2.56 M May 5, 2023
Jeffrey William Henderson Director $2.19 M Apr 25, 2024
Bernadette Connaughton Director $1.92 M Apr 25, 2024
Mark Howard Snyder Svp, Chief Legal Officer $1.84 M Jun 12, 2024
Nicole LaBrosse Svp, Chief Financial Officer $1.84 M -$1.56 M -45.8% Jun 26, 2024
Masaru Matsuda SVP, General Counsel $1 M Sep 4, 2021
Akiko Moni Miyashita Director $922 K Apr 25, 2024
James M. Daly Director $738 K -$875 K -54.2% Aug 11, 2023
Barbara Gayle Duncan Director $728 K Apr 25, 2024
Mahesh Krishnan Director $372 K Apr 25, 2024

Recent Insider Transactions by Companies or Individuals for Halozyme Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership